Biotechnology Markets — October 2, 2026

Technology Overview

Biotechnology is moving from the lab bench to the clinic faster than ever. Gene therapies, AI-designed proteins, precision oncology and blood-based cancer screening are reaching patients and regulators right now. This ebook tracks the companies driving that shift. Biotechnology uses living systems, cells and molecular tools to create medicines, diagnostics, crops and materials. Today it spans mRNA and CRISPR therapeutics, antibody-drug conjugates, stem cell and regenerative medicine, genomic sequencing and bioinformatics.

The companies here cover the full value chain. Global drugmakers and nimble clinical-stage biotechs develop new therapies. Academic medical centers and research institutes generate the discoveries behind them. Contract research and manufacturing organizations turn candidates into trials and products. Tool and sequencing providers, AI labs, regulators, investors, trade associations and specialist media complete the ecosystem. Applications extend well beyond human health, into agricultural genetics, cultivated protein, bio-based chemicals and environmental remediation. For anyone tracking where life-science innovation, capital and partnerships are heading, this is the landscape to watch.

Current Products and News

• Sanofi announced an expanded global alliance with Regeneron on October 1, 2026, covering multiple next-generation, long-acting immunology antibodies.
• Merck & Co, Inc. (MDS) signed an exclusive global license with SciBrunch Therapeutics for SPR2015, an investigational oral KRAS G12D (ON) inhibitor, on September 28, 2026. Days earlier, the FDA approved its WELIREG plus LENVIMA for certain patients with advanced clear cell renal cell carcinoma.
• Food and Drug Administration approved the first heart valve designed to grow with children on October 1, 2026. It also approved the first treatment for MCT8 deficiency and the first gene therapy for pediatric patients with Sanfilippo Syndrome Type A.
• Grail Inc won a favorable FDA Advisory Committee vote on September 23, 2026 for its Galleri multi-cancer early detection test, following its premarket approval application.
• Hutchison China MediTech Ltd (Chi-Med) submitted a US NDA for ORPATHYS plus TAGRISSO in MET-driven, EGFR-mutated lung cancer. It also licensed its KRAS-EGFR antibody conjugate HMPL-A830 to GSK.
• Novotech (Australia) Pty Limited announced on September 25, 2026 that it will acquire Agilex Biolabs. This follows the opening of a new Tokyo office to expand in Japan.
• Google Deepmind released AlphaGenome Atlas in September 2026, a predictive map of every possible DNA letter change in the human genome, alongside SynthID Bio.
• Bayer Global AG secured FDA approval of Kerendia for chronic kidney disease associated with type 1 diabetes, and accelerated approval of sevabertinib for first-line HER2-mutant non-small cell lung cancer.

10 Leading Companies

1. Merck & Co, Inc. (MDS): A global pharmaceutical leader in oncology, vaccines and infectious disease, with fresh momentum from a KRAS inhibitor licensing deal and a new FDA approval.
2. Sanofi: A Paris-based biopharmaceutical major spanning diabetes, specialty care and vaccines, now deepening its immunology pipeline through an expanded Regeneron alliance.
3. Stanford Medicine: A top-ranked academic medical center whose teams just won ARPA-H contracts to apply AI to patient outcomes.
4. Fraunhofer-Gesellschaft: Europe's largest application-oriented research organization, turning out applied life-science advances such as AI osteoporosis detection and bioinks for 3D bioprinting.
5. Rockefeller University: A leading biomedical research university whose recent work includes a large clinical trial showing long-acting antibodies may help control HIV.
6. Gladstone Institute, UCSF: A biomedical research powerhouse behind iPSC technology, now advancing an AI-powered "thinking microscope" and an NIH-funded phage therapy center.
7. Salk Institute for Biological Studies: A globally recognized life sciences institute with an $18 million Bezos Earth Fund grant for AI-driven plant and soil carbon research.
8. Memorial Sloan-Kettering Cancer Institute (MSK): A globally renowned oncology leader that combines patient care with basic, translational and clinical cancer research.
9. Food and Drug Administration: The US regulator shaping the entire sector, with a steady stream of first-of-kind approvals and new initiatives such as an expedited IND pilot.
10. Novotech (Australia) Pty Limited: A leading Asia-Pacific contract research organization that is expanding through its Agilex Biolabs acquisition and new Japanese presence.

Get Ahead in Biotechnology Markets

This market moves every day. On October 2, 2026 alone, 563 companies in this ebook updated their newsrooms. Computer Review puts all 3,206 companies across 63 countries in one place, with 1,987 job pages tracked, so you see the moves as they happen.

With a subscription you can:

• Catch every press release the day it is published
• Know who leads each company and who is hiring
• Size up markets country by country
• Find any company or topic in seconds with keyword search

Start today for just $15 a month, cancel any time, or get the best value at $120 a year and save 33%.

Start your subscription →